Toxicology Menus
CTR uses Liquid Chromatography and Tandem Mass Spectrometry (LC/MS/MS) methods to detect the parent compounds as well as their metabolites in the following tests and/or panels:
ADHD
LC-MS/MS Confirmation and Quantification of the following drugs: Amphetamine, Atomoxetine, Methylphenidate, and Methamphetamine.
Antidepressants
LC-MS/MS Confirmation and Quantification of the following drugs: Amitriptyline, Citalopram, Fluoxetine, Norfluoxetine, Norsertraline, Nortriptyline, Desmethylvenlafaxine, Paroxetine, Quetiapine, Sertraline, Trazodone, Trazodone Metabolite, and Venlafaxine.
Barbiturates
LC-MS/MS Confirmation and Quantification of the following drugs: Butalbital, Phenobarbital.
Drugs Of Abuse
LC-MS/MS Confirmation and Quantification of the following drugs: 6-Acetylmorphine (Heroin), Amphetamine, Benzoylecgonine (Cocaine), Cannabinoids (Marijuana), Methamphetamine, MDA, MDMA (Ecstasy), and Phencyclidine (PCP).
Ethanol Confirmation
LC-MS/MS Confirmation and Quantitation of the following compounds: Ethyl glucuronide (EtG) and Ethyl sulfate (EtS).
Fentanyl and Fentanyl Analogues
3-Methylfentanyl, 4-Fluorobutyryl fentanyl (4-FBF), 4-Fluoroisobutyryl fentanyl (4-FIBF), Acetyl fentanyl, Acetyl norfentanyl, Acryl fentanyl , Alfentanil, Butyryl fentanyl , Carfentanil, Cyclopropyl fentanyl, Despropionylfentanyl (ANPP), Fentanyl, Norfentanyl, Furanyl fentanyl , Isobutyryl fentanyl, Methoxyacetyl fentanyl, o/p-Fluorofentanyl, Sufentanil, Tetrahydrofuranyl fentanyl, Valeryl fentanyl.
Pain Management
LC-MS/MS Confirmation and Quantification of the following drugs: 7-Aminoclonazepam, α-Hydroxyalprazolam, Alprazolam, Carisoprodol, Codeine, Cyclobenzaprine, Dihydrocodeine, Fentanyl, Gabapentin, Hydrocodone, Hydromorphone, Lorazepam, Meprobamate, Methadone, Methadone Metabolite, Morphine, Nordiazepam, Norfentanyl, Norhydrocodone, Noroxycodone, Naltrexone, Oxazepam, Oxycodone, Oxymorphone, Pregabalin, Tapentadol, Temazepam, and Tramadol.
Sleep Medication
LC-MS/MS Confirmation and Quantification of the following drugs: Zolpidem, and Zopiclone.
Suboxone Panel
LC-MS/MS Confirmation and Quantitation of the following compounds: Buprenorphine, Norbuprenorphine, Naloxone.
Urine Drug Screen
Immunoassay identification of the following drug classes: 6-Acetylmorphine, Amphetamines, Benzodiazepines, Buprenorphine, Cocaine, Ethanol, MDMA, MDA, Methadone, Opiates, Oxycodone, THC. Positive test results should be confirmed and quantified via LC-MS/MS testing.
Designer Benzodiazepines
LC-MS/MS Confirmation and Quantitation of the following compounds: 7-Aminoclonazolam, Bromazepam, Clonazolam, Delorazepam, Deschloroetizolam, Estazolam, Etizolam, Flualprazolam, Flubromazolam, Flubromazepam, Meclonazepam, Nifoxipam, Phenazepam, and Pyrazolam.
Xylazine and Medetomidine
LC-MS/MS Confirmation and Quantitation of Xylazine, 4-Hyroxy-xylazine, and Medetomidine in urine.
These panels have been created by CTR to provide the most comprehensive testing procedures for a variety of clinical applications. Any drugs not listed can be developed and added to any panel by request within a matter of weeks.
CTR is currently focused predominantly with urine specimens as metabolite detection provides the most definitive results, cutting down in false positives through cross reactivity and adulteration. Metabolite detection is the only available method to rule out sample adulteration through specimen dosing.